131 related articles for article (PubMed ID: 18570353)
1. Sensing estrogen's many pathways.
Weatherman RV
ACS Chem Biol; 2008 Jun; 3(6):338-40. PubMed ID: 18570353
[TBL] [Abstract][Full Text] [Related]
2. Membrane-initiated steroid signaling action of estrogen and breast cancer.
Song RX
Semin Reprod Med; 2007 May; 25(3):187-97. PubMed ID: 17447208
[TBL] [Abstract][Full Text] [Related]
3. An integrated-molecule-format multicolor probe for monitoring multiple activities of a bioactive small molecule.
Kim SB; Umezawa Y; Kanno KA; Tao H
ACS Chem Biol; 2008 Jun; 3(6):359-72. PubMed ID: 18570355
[TBL] [Abstract][Full Text] [Related]
4. [Modern approaches to estrogen-independent growth of breast tumor].
Krasil'nikov MA
Vopr Onkol; 2004; 50(4):399-405. PubMed ID: 15605761
[No Abstract] [Full Text] [Related]
5. The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer.
Spears M; Bartlett J
Expert Opin Ther Targets; 2009 Jun; 13(6):665-74. PubMed ID: 19456271
[TBL] [Abstract][Full Text] [Related]
6. Rapid extranuclear signaling by the estrogen receptor (ER): MNAR couples ER and Src to the MAP kinase signaling pathway.
Edwards DP; Boonyaratanakornkit V
Mol Interv; 2003 Feb; 3(1):12-5. PubMed ID: 14993433
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
Thomas S; Munster PN
Cancer Lett; 2009 Aug; 280(2):184-91. PubMed ID: 19185986
[TBL] [Abstract][Full Text] [Related]
8. Signaling by estrogens.
Cheskis BJ; Greger JG; Nagpal S; Freedman LP
J Cell Physiol; 2007 Dec; 213(3):610-7. PubMed ID: 17886255
[TBL] [Abstract][Full Text] [Related]
9. Estrogens and SERMs in coronary heart disease.
Regitz-Zagrosek V; Wintermantel TM; Schubert C
Curr Opin Pharmacol; 2007 Apr; 7(2):130-9. PubMed ID: 17317318
[TBL] [Abstract][Full Text] [Related]
10. The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancer.
McDonnell DP
Clin Cancer Res; 2005 Jan; 11(2 Pt 2):871s-7s. PubMed ID: 15701880
[TBL] [Abstract][Full Text] [Related]
11. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin.
Manavathi B; Kumar R
J Cell Physiol; 2006 Jun; 207(3):594-604. PubMed ID: 16270355
[TBL] [Abstract][Full Text] [Related]
12. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
13. Quinoids formed from estrogens and antiestrogens.
Bolton JL; Yu L; Thatcher GR
Methods Enzymol; 2004; 378():110-23. PubMed ID: 15038960
[No Abstract] [Full Text] [Related]
14. Integration of steroid and growth factor pathways in breast cancer: focus on signal transducers and activators of transcription and their potential role in resistance.
Silva CM; Shupnik MA
Mol Endocrinol; 2007 Jul; 21(7):1499-512. PubMed ID: 17456797
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptors: how do they signal and what are their targets.
Heldring N; Pike A; Andersson S; Matthews J; Cheng G; Hartman J; Tujague M; Ström A; Treuter E; Warner M; Gustafsson JA
Physiol Rev; 2007 Jul; 87(3):905-31. PubMed ID: 17615392
[TBL] [Abstract][Full Text] [Related]
16. [Bioluminescent reporter genes].
Allard ST
Postepy Biochem; 2008; 54(4):350-3. PubMed ID: 19248580
[TBL] [Abstract][Full Text] [Related]
17. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
18. Cracking the estrogen receptor's posttranslational code in breast tumors.
Le Romancer M; Poulard C; Cohen P; Sentis S; Renoir JM; Corbo L
Endocr Rev; 2011 Oct; 32(5):597-622. PubMed ID: 21680538
[TBL] [Abstract][Full Text] [Related]
19. Interactions between the estrogen receptor, its cofactors and microRNAs in breast cancer.
McCafferty MP; McNeill RE; Miller N; Kerin MJ
Breast Cancer Res Treat; 2009 Aug; 116(3):425-32. PubMed ID: 19507020
[TBL] [Abstract][Full Text] [Related]
20. Methods of analysis for chemicals that disrupt cellular signaling pathways: risk assessment for potential endocrine disruptors.
Umezawa Y; Ozawa T; Sato M; Inadera H; Kaneko S; Kunimoto M; Hashimoto S
Environ Sci; 2005; 12(1):49-64. PubMed ID: 15793560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
